To provide a portfolio designed to achieve income by investing primarily in US equities in any economic sector whilst participating in long term capital growth.
Name | % Net Assets |
---|---|
Exxon Mobil | 4.2% |
Pfizer | 3.6% |
Chevron | 3.2% |
Verizon Communications | 3.1% |
Johnson & Johnson | 3.1% |
Merck & Co | 2.9% |
Wells Fargo | 2.4% |
Conoco Phillips | 2.0% |
Philip Morris International | 1.9% |
United Technologies | 1.8% |
Key | % Net Assets |
---|---|
Exxon Mobil | 4.2% |
Pfizer | 3.6% |
Chevron | 3.2% |
Verizon Communications | 3.1% |
Other | 85.9% |
Date | 09-Sep-2022 |
---|---|
NAV | 213.90p |
Currency | GBP |
Change | 0.30p |
% | 0.14% |
YTD change | 213.90p |
YTD % | n/a |
Fund Inception | 15/12/2008 |
---|---|
Fund Manager | n/a |
TER | 1.68 (31-Jan-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £100 |
Savings | n/a |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research